Evidence map›Paper›PMID 40018074›Full record

ArticleEndoscopy international open2025

Real-world effectiveness and safety of 1L polyethylene glycol and ascorbic acid for bowel preparation in patients aged 80 years or older.

Salvador Machlab, Vicente Lorenzo-Zúñiga, Miguel Angel Pantaleon, Fernando Sábado, Cátia Arieira, Elena Pérez Arellano, José Cotter, David Carral, Carmen Turbí Disla, Ricardo Gorjão and 2 more

Erratum issuedAbstract read
In one paragraph

Article in Endoscopy international open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Salvador MachlabGastroenterology, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Sabadell, Spain.ORCID 0000-0003-4267-5551
Vicente Lorenzo-ZúñigaGastroenterology, Hospital HM Sant Jordi, Barcelona, Spain.ORCID 0000-0002-4072-3241
Miguel Angel PantaleonGastroenterology, Hospital del Mar, Barcelona, Spain.
Fernando SábadoGastroenterology, Consorcio Hospitalario Provincial de Castelló, Castellón, Spain.ORCID 0000-0003-1602-814X
Cátia ArieiraGastroenterology, Hospital da Senhora da Oliveira, Guimarães, Portugal.ORCID 0000-0001-7381-5532
Elena Pérez ArellanoGastroenterology, Hospital Universitario La Zarzuela, Madrid, Spain.
José CotterGastroenterology, Hospital da Senhora da Oliveira, Guimarães, Portugal.
David CarralGastroenterology, Hospital San Rafael, A Coruña, Spain.
Carmen Turbí DislaMedical Affairs, Norgine, Harefield, United Kingdom of Great Britain and Northern Ireland.
Ricardo GorjãoGastroenterology, Hospital CUF Descobertas, Lisboa, Portugal.
Jose Miguel EstebanGastroenterology, Hospital Clínico Universitario San Carlos, Madrid, Spain.
Sarbelio RodriguezGastroenterology, Hospital Ruber Juan Bravo, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and study aims: Clinical trials and real-world studies show a 1L polyethene glycol and ascorbic acid solution (1L PEG-ASC) to be an effective and safe bowel preparation for colonoscopy in the general population. Here, the effectiveness and safety of 1L PEG-ASC were evaluated in patients aged 80 years or older in a real-world setting. Patients and methods: A post-hoc analysis of an observational, multicenter, retrospective study assessed the effectiveness and safety of 1L PEG-ASC on outpatients aged ≥ 80 years old undergoing colonoscopy at eight centers in Spain and Portugal. Cleansing quality was assessed using the Boston Bowel Preparation Scale, with overall scores ≥ 6 and all segmental scores ≥ 2 considered adequate colon cleansing, and overall scores ≥ 8 or 3 in the right colon considered high-quality cleansing. Cecal intubation rate, withdrawal time, polyp and adenoma detection rates (ADR), and adverse events (AEs) were also monitored. Results: Data were analyzed from 423 patients aged ≥ 80 years; mean age 83.5 years (±3.2) and 49.2% males. The adequate colon cleansing success rate was 88.9%, with high-quality cleansing of the overall and right colon achieved in 54.1% and 46.1% of patients, respectively. Colonoscopy was complete in 94.1% of cases and the ADR was 51.3%. At least one AE was experienced by 4.5% of participants, the most frequent being mild dehydration (2.8%) and nausea (1.2%). Conclusions: This post-hoc analysis confirms 1L PEG-ASC to be an effective and safe bowel cleansing preparation for patients aged 80 years or older in a real-world setting.

Indexed as

Endoscopy Small BowelPerformance and complicationsPreparationQuality and logistical aspects

Identifiers

PMID40018074
PMCPMC11866040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.